stocknshares The U.S. Senate has passed a bill aimed at easing the entrance of biosimilars and other generic drugs onto the U.S. market by preventing drugmakers from creating “patent thickets” to hinder competition. The bill, called the Affordable Prescriptions for Patients Act, was sponsored by U.S. Sens. John Cornyn (R-TX)Continue Reading
Pendopharm, a division of Pharmascience, said it has signed an exclusive distribution agreement with Denmark-based biopharmaceutical company Ascendis Pharma A/S (ASND). Under the terms of the agreement, Pendopharm is responsible for regulatory approval and commercialization of Ascendis’ hypoparathyroidism treatment TransCon PTH in Canada. Financial terms of the agreement are not disclosed.Continue Reading
Jun. 27, 2024 2:02 PM ETS&P 500 Index (SP500)DIS, AAPL, CMS, AMZN, MA, JPM, C, VRTX, NVDA, AZO, PGR, SNPS, STZ, AVB, ACGL, ALB, CE, NEE, NXPI, CZR, ABBV, CRWD, PINSBy: Monica L. Correa, SA News Editor DNY59 Wells Fargo analysts updated their Signature Picks list, an “eclectic” portfolio ofContinue Reading
